Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $400 Price Target

Benzinga · 1d ago
Cantor Fitzgerald analyst Carter Gould reiterates Amgen (NASDAQ:AMGN) with a Neutral and maintains $400 price target.